TELA Bio Stock
TELA Bio, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Heather Getz
- Employees
- 218
- Market cap
- $44 M
- IPO
- 07/11/2019
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for…
TELA Bio stock: price history
1D
-3.5%
1W
-12.2%
1M
-17.4%
6M
+42.8%
YTD
-17.4%
1Y
-35.0%
2Y
-62.5%
5Y
-92.3%
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~67% stronger price swings than usual
Ask the agents about TELA Bio
Analyst assessment of TELA Bio
PRICE TARGET LOW
US$2.00
CONSENSUS
US$2.00
MEDIAN
US$2.00
PRICE TARGET HIGH
US$2.00
0
STRONG BUY
7
BUY
1
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 27/03/2026
TELA Bio stock metrics
P/E
-1.27
P/B
-3.53
EV/EBITDA
-2.13
RETURN ON EQUITY
71.0%
NET MARGIN
-58.4%
DEBT/EQUITY
-3.57
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
74.0%
FLOAT SHARES
33,412,526
AVG. DAILY VOLUME (30D)
218,425
Insider transactions (SEC)
Capper Joseph H
Capper Joseph H
Capper Joseph H
Capper Joseph H
Getz Heather C
Institutional holders
Comparable stocks
Frequently asked questions about TELA Bio stock
What does TELA Bio do?
TELA Bio, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Heather Getz, the company employs around 218 people.
The IPO was on 07/11/2019; the stock trades on NASDAQ under the ticker TELA.
What do analysts say about TELA Bio stock?
8 analysts rate the stock, the consensus is Buy (as of 27/03/2026).
The average price target is US$2.00, ranging from US$2.00 to US$2.00, with a median of US$2.00.
This is an external assessment, not a statement by Market Jury.
When does TELA Bio report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 67% stronger than usual.
Does TELA Bio pay a dividend?
No, TELA Bio currently does not pay a dividend.
Which stocks are comparable to TELA Bio?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get TELA Bio stock analyzed?
Clicking "Analyze stock" lets five strategies assess TELA Bio against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.